The U.S. Chamber of Commerce, in a statement, said India regularly failed to respect intellectual property rights in a range of industries.

WSJ: Novartis Loses Glivec Patent Battle in India

"Bayer is committed to protecting its patents for Nexavar and will rigorously continue to defend our intellectual property rights within the Indian legal system, " the company said in a statement.

NPR: India Rejects Bayer Plea Against Cheap Cancer Drug

"Bayer is committed to protecting its patents for Nexavar and will rigorously continue to defend our intellectual property rights within the Indian legal system, " the company said in a statement quoted by the Associated Press.

BBC: Bayer to challenge India cancer drug ruling